
Harvard Bioscience HBIO
$ 6.1
0.16%
Country |
|
IPO year |
2000 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
44.4 M |
Market Cap[1] |
$ 271 M |
EBITDA (LTM) |
$ -48.6 M |
P/E (LTM) |
-2.72 |
P/S (LTM) |
2.87 |
EPS (LTM) |
-1.99 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Pro-Dex
PDEX
|
$ 58.57 | 3.39 % | $ 193 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 85.01 | 1.99 % | $ 5.03 B | Nasdaq Global Select Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 141.01 | -1.8 % | $ 7.93 M | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
ResMed
RMD
|
$ 210.98 | 1.05 % | $ 31 B | NYSE,SPB | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
electroCore
ECOR
|
$ 6.09 | -3.26 % | $ 51.7 K | Nasdaq Global Select Market | ||
|
BioLife Solutions
BLFS
|
$ 31.28 | -1.14 % | $ 1.49 B | Nasdaq Global Select Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
STERIS plc
STE
|
$ 228.4 | -1.22 % | $ 22.4 B | NYSE,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AtriCure
ATRC
|
$ 37.76 | -5.95 % | $ 1.8 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 13.37 | -2.69 % | $ 2.67 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 3.39 | -3.14 % | $ 36 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 85.54 | 0.85 % | $ 4.04 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 72.32 | -0.45 % | $ 14.4 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 14.79 | 0.14 % | $ 614 M | Nasdaq Global Select Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 117.17 | -1.6 % | $ 3.75 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.14 | -0.54 % | $ 189 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 166.72 | -1.07 % | $ 9.53 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 26.16 | -2.28 % | $ 13.4 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 168.51 | 0.08 % | $ 4.15 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 353.33 | 0.1 % | $ 126 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 68.94 | -0.99 % | $ 40.4 B | NYSE | ||
|
Pulse Biosciences
PLSE
|
$ 35.13 | 0.26 % | $ 2.37 B | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.4 | 2.02 % | $ 32.8 M | NYSE American | ||
|
Envista Holdings Corporation
NVST
|
$ 27.31 | -1.69 % | $ 4.59 B | NYSE | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.72 | -1.15 % | $ 78.8 M | Nasdaq Global Select Market | ||
|
STAAR Surgical Company
STAA
|
$ 24.36 | 0.58 % | $ 1.21 B | Nasdaq Global Market,SPB | ||
|
Stereotaxis
STXS
|
$ 1.26 | -5.26 % | $ 115 M | NYSE American | ||
|
Repro Med Systems
KRMD
|
$ 4.11 | - | $ 190 M | Nasdaq Capital Market | ||
|
OraSure Technologies
OSUR
|
$ 4.05 | 2.02 % | $ 298 M | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 136.71 | 3.3 % | $ 6.1 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 101.32 | -0.85 % | $ 2.29 B | Nasdaq Global Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 165.62 | 0.04 % | $ 47.6 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.66 | -1.46 % | $ 19.8 M | NYSE American | ||
|
West Pharmaceutical Services
WST
|
$ 340.96 | 0.4 % | $ 24.7 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 70.52 | 1.37 % | $ 228 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.